Don't Miss
Most Read
Trending on GB News
Fewer than ten weeks of Labour being in charge and the Great Brexit betrayal is already underway.
Government sources have briefed The Times that ministers are willing to give ground on a youth mobility scheme that would give young EU citizens the right to work in the UK, and that could be thousands of them.
If this happens, it is merely the first of many steps towards bringing us back under the yoke of the European Union.
One of the key reasons for leaving the European Union was a rejection of mass migration. And today some legal migration figures came out that showed the last Conservative Government's policies were beginning to work.
Jacob Rees-Mogg offers his view on an EU mobility scheme
GB News
So a move like this would represent a betrayal of one of the greatest democratic exercises in British history.
But Government sources picked the wrong day to brief the papers about this signal that the UK is moving back into alignment with Europe.
You may have seen the deeply encouraging news that the United Kingdom has approved Lecanemab, the first-ever Alzheimer's drug that has been shown to slow cognitive decline by about 27 per cent.
The United States has approved the drug too. But lo and behold, the European Union has rejected this drug owing to concerns about side effects.
Its ever-present precautionary principle means that people can't get life-saving treatments that will make their standard of living and their experience in old age so much better. Why when people are suffering from Alzheimer's, would the EU not allow patients who would be well informed of the side effects to at least try a new drug that is the first to be shown to delay some symptoms?
Because the European Union is an overly regulated and overly risk-averse institution, which we're lucky to be out of. Sir Keir Starmer, whether he pursues a youth mobility agreement or not, clearly wants to pursue closer ties with the EU.
But this decision from the EU regulators is a microcosm for why the Prime Minister should not look to align further with the European Union, and the question that arises is whether this Alzheimer's drug will be available in Northern Ireland, which is compulsorily aligned with the European Union.
The EU prides itself on its high level of regulatory interference, which it pursues regardless of the consequences. In reality, what it does is to stifle economic growth, which lowers everyone's standard of living.
Compare the size of the US and EU economies over recent years. In 2010, both economies are roughly the same size about $15trillion in GDP. But nearly 15 years later, the UK economy and the EU economy have barely grown to $18trillion, while the US economy has steamed ahead to $23trillion.
This gap ought to tell the Prime Minister everything he needs to know. The future of British prosperity does not lie with the EU, but with the United States and the Pacific.
Not only should he resist any temptation to implement a youth mobility scheme, but he should focus on alignment with the serious economies overseas to unleash Britain's economy and improve living standards for all.